Chemistry of Lithium Enolates
Chemistry of Lithium Enolates
批准号:
7880467
负责人:
DAVID B. COLLUM
金额:
$30.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-01 至 2014-04-30
关键词:
3-hydroxybutanalAcylationAlkylationAnti-Asthmatic AgentsCase StudyChemistryCollaborationsColorectal CancerDNA Sequence RearrangementDrug IndustryFosteringFundingGroup ProcessesInvestigationKineticsLaboratoriesLithiumMethodsNMR SpectroscopyOrganic SynthesisPharmacologic SubstancePhysical condensationProcessProtocols documentationReactionReagentSolutionsStagingStructureabstractingbasecomputational chemistrydesignimprovedprogramspublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract Lithium enolates constitute one of he most important classes of reactive intermediate in organic synthesis. The pharmaceutical industry uses these reagents frequently and on very large scales. In this proposal we describe efforts to understand the underlying chemistry of the most important reactions of lithium enolates. With methods to establish solution structures that dominated the first funding period largely developed, structural studies will be more targeted in support of mechanistic studies. In the most general sense, we will examine how solvation and aggregation influence reactivity. The mechanistic investigations will focus on specific classes of reaction-case studies-that include: (1) aza-aldol condensations; (2) O-silylations; (3) alkylations; (4) acylations; (5) [2,3]- and [3,3]-sigmatropic rearrangements; and (6) nucleophilic aromatic substitutions (SNAr). A uniquely integrated approach based on a combination of NMR spectroscopy, solution kinetics, and computational chemistry will develop an understanding of the mechanistic principles and how to control reactivity and selectivity. By bringing synthetic organic, physical organic, analytical, and computational chemistry together under one roof, we reveal the consequences of solvation and aggregation with an unprecedented clarity.
PUBLIC HEALTH RELEVANCE: Project Narrative Lithium enolates are reactive intermediates used by other academic and pharmaceutical process chemistry laboratories on a daily basis around the globe. Our mechanistic studies described herein are designed to understand and improve their efficacy. The project originated from collaboration with Sanofi-Aventis to develop anti-asthmatics. The proposed funding period includes a collaboration with Amgen as part of their program to synthesize treatments for colorectal cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
-
批准号:10393518
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2019
-
负责人:DAVID B. COLLUM
-
依托单位:
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
-
批准号:9912165
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2019
-
负责人:DAVID B. COLLUM
-
依托单位:
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
-
批准号:10605229
-
项目类别:
-
资助金额:$55.76万
-
财政年份:2019
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:9267478
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:7617824
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:8069864
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:7072393
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:8966974
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:7227515
-
项目类别:
-
资助金额:$29.13万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:8259484
-
项目类别:
-
资助金额:$31.29万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:8690215
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:8458131
-
项目类别:
-
资助金额:$30.17万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
Chemistry of Lithium Enolates
-
批准号:7414400
-
项目类别:
-
资助金额:$29.08万
-
财政年份:2006
-
负责人:DAVID B. COLLUM
-
依托单位:
ASYMMETRIC 1,2-ADDITIONS
-
批准号:2447488
-
项目类别:
-
资助金额:$24.7万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
ASYMMETRIC 1,2-ADDITIONS
-
批准号:6138591
-
项目类别:
-
资助金额:$23.37万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
ASYMMETRIC 1,2-ADDITIONS
-
批准号:6342960
-
项目类别:
-
资助金额:$23.85万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
Asymmetric 1,2-Additions
-
批准号:6697046
-
项目类别:
-
资助金额:$25.07万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
Asymmetric 1,2-Additions
-
批准号:6621043
-
项目类别:
-
资助金额:$24.94万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
Asymmetric 1,2-Additions
-
批准号:6833967
-
项目类别:
-
资助金额:$25.07万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
Asymmetric 1,2-Additions
-
批准号:6430157
-
项目类别:
-
资助金额:$25.62万
-
财政年份:1998
-
负责人:DAVID B. COLLUM
-
依托单位:
海外基金